Cargando…
Modification of i-GONAD Suitable for Production of Genome-Edited C57BL/6 Inbred Mouse Strain
Improved genome editing via oviductal nucleic acid delivery (i-GONAD) is a novel method for producing genome-edited mice in the absence of ex vivo handling of zygotes. i-GONAD involves the intraoviductal injection of clustered regularly interspaced short palindromic repeats (CRISPR) ribonucleoprotei...
Autores principales: | Kobayashi, Yukari, Aoshima, Takuya, Ito, Ryota, Shinmura, Ryota, Ohtsuka, Masato, Akasaka, Eri, Sato, Masahiro, Takabayashi, Shuji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226992/ https://www.ncbi.nlm.nih.gov/pubmed/32295056 http://dx.doi.org/10.3390/cells9040957 |
Ejemplares similares
-
i-GONAD (improved genome-editing via oviductal nucleic acids delivery), a convenient in vivo tool to produce genome-edited rats
por: Takabayashi, Shuji, et al.
Publicado: (2018) -
Modification of improved-genome editing via oviductal nucleic acids delivery (i-GONAD)-mediated knock-in in rats
por: Aoshima, Takuya, et al.
Publicado: (2021) -
Recent Advances and Future Perspectives of In Vivo Targeted Delivery of Genome-Editing Reagents to Germ cells, Embryos, and Fetuses in Mice
por: Sato, Masahiro, et al.
Publicado: (2020) -
Sequential i-GONAD: An Improved In Vivo Technique for CRISPR/Cas9-Based Genetic Manipulations in Mice
por: Sato, Masahiro, et al.
Publicado: (2020) -
Successful i-GONAD in Mice at Early Zygote Stage through In Vivo Electroporation Three Min after Intraoviductal Instillation of CRISPR-Ribonucleoprotein
por: Takabayashi, Shuji, et al.
Publicado: (2022)